Zhangzhou, China

Jinxia Lin


 

Average Co-Inventor Count = 9.2

ph-index = 1


Company Filing History:


Years Active: 2022-2023

where 'Filed Patents' based on already Granted Patents

4 patents (USPTO):

Title: Innovations and Contributions of Jinxia Lin

Introduction

Jinxia Lin is a notable inventor based in Zhangzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address various medical conditions. With a total of four patents to his name, Lin's work is recognized for its potential impact on drug development.

Latest Patents

Among his latest patents is the "Crystal form of pyrrolidinyl urea derivative and application thereof." This invention discloses a crystal form of a TrkA inhibitor, along with a preparation method and its application in creating drugs for treating diseases associated with pain, cancer, inflammation, neurodegenerative diseases, and certain infectious diseases. Another significant patent is the "Crystal form D of pyrazine-2(1H)-ketone compound and preparation method therefor." This patent details a method for preparing a compound of formula (II) and its corresponding crystal form.

Career Highlights

Jinxia Lin has worked with prominent companies in the pharmaceutical industry, including Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. and Medshine Discovery Inc. His experience in these organizations has contributed to his expertise in drug formulation and development.

Collaborations

Lin has collaborated with several professionals in his field, including Shuhui Chen and Fei Hong. These collaborations have likely enhanced his research and development efforts, leading to innovative solutions in pharmaceuticals.

Conclusion

Jinxia Lin's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…